Related Experiment Video
Updated: Apr 22, 2026
09:54
Synthesis and Characterization of 1,2-Dithiolane Modified Self-Assembling Peptides
Published on: August 20, 2018
6.8K
[Occupational asthma caused by maleic anhydride]
Martin Rune Hansen1, Flemming Lander, Tina Skjold
1Sektion for Miljø, Arbejde og Sundhed, Institut for Folkesundhed, Aarhus Universitet, Bartholins Allé 2, 8000 Aarhus C.
Ugeskrift for Laeger
|October 9, 2014
Summary
Organic acid anhydrides (OAA) can cause occupational asthma. This study documents the first case of asthma caused by maleic anhydride (MA) exposure in insecticide production, highlighting sensitization risks.
Area of Science:
- Occupational medicine
- Immunology
- Chemical safety
Background:
- Organic acid anhydrides (OAA) are prevalent industrial chemicals with known irritant and sensitizing properties.
- Occupational asthma is a significant concern in industries utilizing OAA, necessitating identification of specific causative agents.
- Maleic anhydride (MA) is a common OAA used in various chemical manufacturing processes.
Observation:
- A 60-year-old male worker in insecticide production developed respiratory symptoms linked to his work environment.
- Symptoms appeared after eight years of intermittent exposure to maleic anhydride (MA).
- Peak expiratory flow (PEF) measurements revealed significantly higher variability on workdays compared to non-workdays.
Findings:
- The case presents the first documented instance of occupational asthma attributed to maleic anhydride (MA) exposure.
- Diagnostic tests confirmed sensitization to MA, including a positive basophil activation test and elevated MA-specific IgE levels in serum.
- The findings establish a direct link between MA exposure and the development of work-related asthma.
Implications:
- This case underscores the potential for MA to induce occupational asthma, even with intermittent exposure.
- Highlights the importance of recognizing MA as a respiratory sensitizer in occupational health surveillance.
- Emphasizes the need for stringent exposure controls and monitoring in industries where MA is handled to prevent occupational asthma.
Related Concept Videos
01:29Asthma-I: Introduction
3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:26Asthma-II: Pathophysiology and Classification
4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
2.1K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
2.1K
01:13Asthma III: Clinical Manifestations
25
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
25
01:28Asthma I: Introduction
40
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
40